Iron metabolism disorders of patients with chronic paracoccidioidomycosis

Paracoccidioidomycosis (PCM) is caused by Paracoccidioides spp.; during infection, some host mechanisms limit the availability of iron, thereby reducing its reproduction. However, Paracoccidioides spp. can evade the immune defense and, even under limited iron conditions, use this mineral for growth and dissemination. This study evaluated the iron metabolism of 39 patients who were diagnosed with chronic PCM between 2013 and 2021. The forms of iron before treatment and at the time of clinical cure were evaluated based on the following: serum ferritin levels (storage iron); total iron-binding capacity (TIBC) and transferrin saturation (TSAT) level (transport iron); red blood cell (RBC), hemoglobin (Hb), hematocrit (HCT), and soluble transferrin receptor (sTfR) levels; and sTfR/log ferritin ratio (functional iron). The mean age of the patients was 54.5 years ({+/-}6.7 years). Most patients were men (97.4%), rural workers (92.1%), and smokers (84.6%); most had moderate disease severity (66.7%). Before treatment, the median values of all evaluated parameters were within or just slightly outside the normal range of values. However, it is possible to infer that PCM interferes with functional and storage iron because improvements in these parameters after treatment as well as associations with disease severity were observed. Furthermore, moderate correlations were observed between C-reactive protein and the Hb (r=-0.500; p=0.002), RBC (r=-0.461; p=0.005), HCT (r=-0.514; p=0.001), and iron levels (r=-0.491; p=0.002). PCM interferes with iron metabolism by transforming functional iron to storage iron, as revealed by anemia, low iron levels with normal TSAT levels, normal TIBC, normal sTfR levels, normal sTfR/log ferritin ratios, and normal or slightly increased ferritin levels. PCM can lead to anemia of inflammation, which can be differentiated from iron deficiency anemia by a careful investigation of the iron form parameters.


69
Iron is an essential component of hemoglobin (Hb), myoglobin, and several enzymes,

70
and it has a fundamental role in oxygen transport and electron transfer. Additionally, it acts 71 as a cofactor in many enzymatic processes, including DNA synthesis [5][6][7] .

72
Maintaining control of iron homeostasis is essential in host-pathogen interactions 73 because both compete for this micronutrient. During infection, some host immune 74 mechanisms limit the availability of iron to invading microorganisms, thereby reducing their 75 proliferation [8]. However, many microorganisms, such as Paracoccidioides spp., can evade 76 the immune defense; even under limited iron conditions, they can use this mineral for growth . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

79
In the human body, iron is distributed in different interconnected forms to enable 80 homeostasis. These forms of iron (storage iron, transport iron, and functional iron) can be 81 evaluated separately using laboratory tests, many of which are available and accessible 82 during routine laboratory testing. These tests can assess any disturbances in iron metabolism 83 and the affected iron form [11]. Generally, when there is an iron deficit, these forms are 84 sequentially affected. First, there is a decrease in the storage iron levels, followed by a 85 deficiency in the transport iron level and a reduction in the functional iron level [12,13].

86
The host-parasite interaction and consequent inflammatory response lead to changes 87 in iron metabolism dynamics. These changes can be observed in some patients with PCM   . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 14, 2023. ; https://doi.org/10.1101/2023.02.10.23285778 doi: medRxiv preprint 8 144 Transport iron: Transport iron is iron that circulates in the body. The total iron-binding 145 capacity (TIBC) was measured using a colorimetric assay (Roche) and the transferrin 146 saturation (TSAT) level, which was calculated as [TSAT = serum iron/TIBC × (100)]; the 147 result was expressed as a percentage (%).
148 Functional iron: Functional iron is related to erythrocyte synthesis and erythropoiesis.
149 Therefore, to evaluate functional iron, the blood count (HMG test) was evaluated to measure 150 the Hb level, red blood cell (RBC), level mean corpuscular volume, and mean Hb 151 concentration (MHC) (XN 3000 series hematology equipment; Sysmex Corporation, Kobe, 152 Japan). Serum iron was determined using a colorimetric assay (Roche). The soluble 153 transferrin receptor (sTfR) level was determined using an enzyme-linked immunosorbent 154 assay (human sTfR ELISA Kit; Elabscience). This test is not routinely performed; therefore, 155 serum stored in the PCM biobank was used.

156
The inflammatory process was assessed according to the high-sensitivity serum C-157 reactive protein (CRP) level measured using immunoturbidimetry. All analyzed parameters 158 and values considered normal by the manufacturer are listed in Table 1.

159
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 14, 2023. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

177
A total of 88 patients were diagnosed with chronic PCM during the study period. Of 178 these, 35 patients were excluded according to the criteria and 39 patients participated in the 179 study (Fig 1). The mean age of these patients was 54.5 years (SD, 6.70 years); 38 (97.4%) 180 were men and 35 (92.1%) were rural workers. Thirty-three (84.6%) individuals were smokers 181 at the time of diagnosis. Regarding disease severity, 66.7% of the patients had moderate 182 disease, 20.5% had severe disease, and 12.8% had mild disease ( Table 2).

183
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 186 HIV, human immunodeficiency virus.

187
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 199 An analysis of the median values showed that those at the time of clinical cure were reduced 200 compared to those before treatment (p = 0.017) (Fig 2).  212 Similarly, an analysis of the median TSAT values showed no statistical differences between 213 those before treatment and those at the time of clinical cure ( Table 3).

219
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 14, 2023. ; https://doi.org/10.1101/2023.02.10.23285778 doi: medRxiv preprint During the healing process of these patients, the anemia frequency and HCT levels 238 were significantly reduced ( Table 4). These improvements with treatment were also 239 observed when evaluating the mean values, which were significantly increased at the time of 240 clinical cure compared to those before treatment ( Table 5).

241
Before treatment, more than half of the patients (n =22; 56.4%) had lower than normal 242 serum iron levels; however, at the time of clinical cure, the percentage of patients with lower 243 than normal serum iron levels was significantly reduced ( Table 4). It was also noted that the 244 mean values of these patients increased significantly with the use of antifungal treatment 245 ( Table 5). The sTfR levels and sTfR/log ferritin ratios before treatment and at the time of 246 clinical cure were not significantly different ( Table 5).
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 14, 2023. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 263 However, an analysis of the median values of each disease stage showed a significant 264 reduction in the values at the time of clinical cure compared to those before treatment (Fig   265 3).  (Fig 4). At the time of clinical cure, no correlations were 276 observed between the CRP levels and these variables. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

283
An analysis of the stored iron and functional iron parameters before treatment showed 284 a significant difference between values associated with severe and mild/moderate disease 285 cases as well as CRP levels ( Table 6).

286
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 14, 2023. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 14, 2023. ; https://doi.org/10.1101/2023.02.10.23285778 doi: medRxiv preprint 22 298 actively control intracellular and systemic iron levels in a way that can contain infection 299 and/or microbial persistence. Therefore, this study compared iron metabolism parameters 300 before treatment and at the time of clinical cure, analyzed them based on PCM severity, and 301 correlated them with the intensity of the inflammatory process in patients with chronic PCM.

302
The demographic and clinical characteristics of the patients corresponded to those 303 reported by other case series studies of chronic PCM that involved mostly male patients who 304 were older than age 40 years, smokers, rural workers, and had moderate PCM [18][19][20][21][22].
305 Therefore, this sample is representative of the population of PCM patients and allows the 306 generalization of our results.

307
The storage iron evaluated during this study had higher median serum ferritin levels 308 before treatment, but they were within the normal range. Although ferritin exists in large 309 amounts in the liver and spleen, only a small amount is detected in the circulation. However, 310 serum quantification is a common and non-invasive method that provides an accurate . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. To assess the transport iron, we evaluated the TIBC, TSAT level, and serum 323 iron/TIBC ratio. Before treatment, the patients in this study had median values that were 324 slightly lower than normal, indicating a non-significant transport iron deficit. Additionally, 325 antifungal therapy did not affect these parameters. A weak negative correlation was observed 326 between the TIBC and CRP level, but no correlation was observed between the TSAT and 327 CRP levels. The TIBC is an indirect measure of circulating transferrin, which can be reduced 328 during inflammatory processes [11]. Therefore, with chronic PCM, the transport iron 329 parameters are less affected than the storage iron and functional iron parameters.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

366
The sTfR level is a good indicator of the iron status in the absence of systemic 367 influences; therefore, we analyzed sTfR levels before treatment and at the time of clinical 368 cure. Our results showed that the median values before treatment were normal and did not 369 decrease after treatment, suggesting that the body iron is normal; however, it is distributed . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 371 During the storage iron reduction phase, the sTfR level does not change. However, when 372 there is a decrease in functional iron, the synthesis of the transferrin receptor is stimulated; 373 consequently, the sTfR level increases. This parameter is mainly recommended for 374 differentiating iron deficiency anemia from inflammation anemia/chronic disease anemia 375 because the value is increased with iron deficiency anemia but normal with inflammation 376 anemia [39-41]. Studies of pulmonary tuberculosis patients suggested that high sTfR levels 377 in patients with anemia indicate probable iron deficiency and recommended that the sTfR 378 concentration of patients with anemia and an infectious/inflammatory process should be 379 examined [28].

380
Another good indicator of iron deficiency with differential anemia is the sTfR/log 381 ferritin ratio [42]. During our study, the sTfR/log ferritin ratio as well as sTfR level were 382 normal before treatment and did not significantly change after treatment, reinforcing the 383 belief that anemia with chronic PCM is inflammation anemia.

384
This study presents some limitations. The number of patients is apparently low.

388
In conclusion, PCM interferes with iron metabolism by shifting functional iron to 389 storage iron, as revealed by anemia and low iron levels, with normal TSAT and sTfR levels, 390 normal TIBC, and normal sTfR/log ferritin ratio. Normal or slightly increased ferritin levels, 391 which are characteristic of inflammatory anemia, were observed. However, it should be noted 392 that a few patients had iron deficiency anemia. Therefore, a careful investigation of the iron 393 parameters is important to the clinical management of PCM.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 14, 2023. ; https://doi.org/10.1101/2023.02.10.23285778 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 14, 2023. ; https://doi.org/10.1101/2023.02.10.23285778 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 14, 2023. ; https://doi.org/10.1101/2023.02.10.23285778 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 14, 2023. ; https://doi.org/10.1101/2023.02.10.23285778 doi: medRxiv preprint